The prognosis for this stock is exceedingly healthy and hence is a LT stock to put away in the bottom draw. I will be buying in the dips short term until I accumulate 1M.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
